At a glance
- Originator VULM
- Developer Zentiva
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 15 Sep 2003 Slovakofarma has merged with Leciva to form Zentiva
- 31 Dec 2001 This agent is still in active development
- 04 May 1999 Preclinical development for Hypertension in Slovakia (Unknown route)